Thompson Davis & Co’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,575
Closed -$529K 108
2023
Q3
$529K Buy
11,575
+2,400
+26% +$111K 0.65% 26
2023
Q2
$378K Sell
9,175
-34,440
-79% -$1.13M 0.43% 47
2023
Q1
$1.35M Buy
43,615
+13,945
+47% +$449K 1.77% 10
2022
Q4
$596K Sell
29,670
-13,370
-31% -$286K 0.85% 24
2022
Q3
$607K Sell
43,040
-5,585
-11% -$75.2K 0.82% 21
2022
Q2
$365K Buy
48,625
+25,925
+114% +$215K 0.6% 36
2022
Q1
$231K Sell
22,700
-13,935
-38% -$178K 0.28% 75
2021
Q4
$886K Buy
+36,635
New +$716K 0.74% 21
2014
Q4
Sell
-5,000
Closed -$13K 1160
2014
Q3
$13K Buy
+5,000
New +$13.1K 0.02% 598

Other funds holding AEHR

Thompson Davis & Co's AEHR Position: Q4 2023 in Review

Thompson Davis & Co sold out of Aehr Test Systems (AEHR) in Q4 2023, closing a stake of 11,575 shares — an estimated $529K sold.

Thompson Davis & Co first reported a position in AEHR in Q3 2014 and held it in 9 quarters. The position peaked at $1.35M in Q1 2023. 168 funds tracked by Wall St. Rank hold AEHR as of Q4 2023.

  • Thompson Davis & Co reported no remaining Aehr Test Systems position as of Q4 2023 after selling out during the quarter.
  • Thompson Davis & Co sold 11,575 Aehr Test Systems shares in Q4 2023, an estimated $529K.
  • Thompson Davis & Co first reported a position in Aehr Test Systems in Q3 2014 and held it in 9 quarters.
  • Thompson Davis & Co's Aehr Test Systems position peaked at $1.35M in Q1 2023.
  • 168 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2023.

Based on Thompson Davis & Co's 13F filing for Q4 2023, filed 5 Feb 2024.